Carina S. Minardi, PhD, MPH

Director of Genomic Medicine and Digital Health Programs, Vibrent Health

Carina S. Minardi is a research and commercial leader with a passion for technology that supports human subject research and clinical applications. She is responsible for defining and guiding the organization’s overall commercial and business development strategy, ensuring new and consistent business growth for the organization.

Prior to joining Vibrent Health, Dr. Minardi oversaw the operational infrastructure of the Partner team at Truveta as well as spearheaded its technological partnerships. She also led the strategy and portfolio development and execution for Kaiser Permanente’s Washington region’s Quality and Safety, Member Experience, and medical group Branding and Communications for over 700,000 members and 1,200 clinicians in the state of Washington.

Prior to entering the healthcare arena, Dr. Minardi began her academic career as a National Science Foundation Fellow at Georgetown University where she obtained her Master’s and Doctorate in analytical chemistry. Her research focused on the exploration of ionization mechanisms for mass spectrometric analysis of small molecules, large molecules, and single cell analysis for -omics studies. Dr. Minardi also holds a Master’s in Public Health from Yale University with a focus on health policy and administration.

Praduman “PJ” Jain

Founder and CEO, Vibrent Health 

Contact PI, NIH Precision Medicine Consortium & All of Us Research Program Technology Center 

Principle Investigator, NIH AIM-AHEAD Consortium & AI/ML to reduce health disparities and mitigate bias 

Praduman Jain, known to colleagues as “PJ,” is the CEO and founder of Vibrent Health and the principal investigator of the Participant Technology Systems Center of the National Institutes of Health’s All of Us Research Program. Under Jain’s leadership, the NIH awarded Vibrent $75 million in 2017 and an additional award in 2020 — with initial first-year funding of $39 million — to build and manage a national platform for health research for one million people across the US over the program’s expected span of 10 or more years. In 2020, Vibrent received more than $4 million in funds from the NIH to build next-generation technology for COVID-19 screening, testing, and contact tracing. Jain is also the chair of the security board of the Committee on Access, Privacy, and Security for the NIH All of Us Research Program. Before founding Vibrent, Jain held various senior leadership roles at Sprint, Nextel, AOL, Time Warner, and VTech and launched emerging products and services with revenues of more than $2 billion. He earned a Master of Science degree in electrical engineering, holds several patents, and has authored several research publications.